It’s estimated that in 2019, nearly 500,000 deaths were caused by asthma – a noncommunicable disease that affects the airways by narrowing them, causing them to swell and sometimes producing extra mucus. Asthma symptoms include difficulties breathing, coughing, wheezing and a shortness of breath, with the severity varying significantly between sufferers.
It is the most common chronic condition affecting children, with 1 in 12 said to be asthmatic (that’s around 6 million in the US between the ages of 0 to 17). Advances in medication allow many to minimise serious issues through the use of preventative inhalers, alongside avoidance of asthma triggers (allergens and irritants) and leading a healthy lifestyle.
However, asthma cannot be cured and for some, an asthma attack can be life-threatening. And that is especially so for those in low and lower-middle income countries. This is where asthma is predominantly under-diagnosed and under-treated – leading to the majority of global deaths each year. Which is to say that mortality from asthma could be greatly reduced with access to better healthcare and treatment, and this is something the Global Initiative for Asthma (GINA) is looking to highlight this World Asthma Day (Tuesday 3rd of May, 2022).
The theme is ‘Closing Gaps in Asthma Care’, with a challenge being set to international respiratory communities to “work together with colleagues, patients and healthcare providers to identify, help implement and share innovative solutions both locally and globally”.
We certainly hope that the sharing of these asthmatic and respiratory journals assist with this objective.
Impact factor: is based on Web of Science data and only includes documents such as articles and reviews. It measures the average number of times an article is cited by other journal articles and documents. An impact factor of 3 or more is considered good, 1 is average. This list uses the 2-year impact factor from SCImago.
CiteScore: is based on Scopus data for all indexed documents, including articles, letters and editorials. Like impact factor, it measures the average citations received per document published in a journal over a 4-year time period
Allergy, Asthma and Immunology Research
Impact Factor: 4.281
The Allergy, Asthma & Immunology Research journal is published bi-monthly by the Korean Academy of Asthma, Allergy and Clinical Immunology. The open-access, peer-reviewed journal features original research, brief communications and reviews in the specialties of allergy, asthma and immunology. Editorials and letters to the Editor explore controversial issues and encourage further discussion among physicians in the related medical fields.
Journal of Asthma & Allergy
Impact Factor: 4.258
Published by Dovepress, the Journal of Asthma and Allergy is an open-access, international journal that publishes original research, reports, editorials and commentaries on asthma and other related medical conditions. The main focus is to publish research and clinical results in humans, however preclinical, animal and in vitro studies are published where they shed light on disease processes and potential new therapies.
The Journal of Allergy and Clinical Immunology
Impact Factor: 10.228
The Journal of Allergy and Clinical Immunology is the most cited journal in the field of allergy and clinical immunology, and is an official publication of the American Academy of Allergy, Asthma and Immunology (AAAI). Published monthly, it features the very latest research in the allergy/immunology speciality, with a particular focus on clinical medicine and basic science – as it translates into optimal patient care. Articles cover such topics as asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases.
European Respiratory Journal
Impact Factor: 12.339
The European Respiratory Journal is the official scientific journal of the European Respiratory Society, and features cutting-edge clinical and experimental work in the field of respiratory medicine. From original articles, to task force reports and guidelines, it is published continuously online and is collected into 12 monthly issues in two volumes per year. The ERJ is the most highly regarded peer-reviewed respiratory journal in Europe.
Impact Factor: 3.095
The Respiratory Medicine Journal is internationally-renowned for its devotion to the rapid publication of clinically-relevant respiratory medicine research. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders and the role of allergens and pollutants. It is increasingly the journal of choice for the publication of phased trial work, commenting on effectiveness, dosage and methods of action.
Annals of the American Thoracic Society
Impact Factor: 6.831
The Annals of the American Thoracic Society is the official journal of the American Thoracic Society and publishes clinical trials, original research, ATS documents, systematic reviews and case conferences. These are all in relation to clinical, epidemiological and health services research in adult and paediatric pulmonary, respiratory, critical care medicine, sleep and population health.
Impact Factor: 4.88
Respirology publishes peer-reviewed articles of clinical and clinically-relevant experimental respiratory biology and disease. The journal aims to encourage the international exchange of results and publishes papers in categories from original articles, to editorials, commentaries, reviews, letters and correspondences. It is the official journal of the Asia Pacific Society of Respirology and is the preferred journal of the Thoracic Society of Australia and New Zealand. Two of its most cited articles in 2020 were ‘Treatable traits can be identified in a severe asthma registry and predict future exacerbations’ and ‘Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma’.
American Journal of Respiratory Cell and Molecular Biology
Impact Factor: 6.914
The American Journal of Respiratory Cell and Molecular Biology reports significant and original observations in the area of respiratory and lung cell biology. Focus includes cellular, biochemical, molecular, developmental, genetic and immunologic studies in health and in acute and chronic disorders related to the respiratory system. It is published monthly and has a worldwide circulation of 8,500.